Information about the Aspen Ideas Festival is here. I am scheduled for a session, The American Wellness Paradox, currently scheduled from 11:00-11:50 a.m., at the East Lawn Tent. This will be a discussion with senior HHS policy advisor, Calley Means. Here’s the blurb on it: “Americans are spending more than ever on healthcare, supplements, wellness trends, and “clean eating,” yet rates of chronic disease and metabolic illness continue to climb. As skepticism fuels the rise of movements like MAHA, debates over what Americans should eat have become deeply cultural, political, and economic. Two influential voices with sharply different perspectives on nutrition and food science explore how food systems, farming practices, consumer culture, and the wellness industry collided to create one of the defining public health debates of our time.”
by Marion Nestle
May
21
2026
The effects of GLP-1 drugs on the food industry: A collection of recent items
You might think of GLP-1 drugs as miracles of modern medicine, but the food industry views them as a threat.
Why? Eating less is bad for business.
The Threat
- Data: Alarming new research reveals threat GLP-1s pose to food and drink sector: New research has revealed that as many as 8% of Britons now use weight loss drugs, with a further 14% considering their use in the future…. Read more
- GLP-1 in real life: Smaller shops, fewer ultra-processed foods: Enough with the predictions. How are GLP-1 drugs actually impacting purchasing behaviour?… Read more
- FoodDive: How GLP-1s are shaking up snacking: GLP1-s are reshaping how Americans eat, pushing more consumers toward smaller portions and nutrient-dense options packed with ingredients like protein or fiber. As sales for traditional packaged snacks decline, food companies are now rushing to tap into this fast-growing market.
- What is the ‘GLP-1 halo effect’? The GLP-1 craze could end up changing more diets than expected – even those of non-GLP-1 users…. Read more
- GLP-1s: Is the industry asking the wrong question? New data and clinical insight suggest the real impact of GLP-1 drugs isn’t less eating – it’s a rethink of how, when and why people eat… Read more
How food companies are responding
- How GLP-1s are reshaping product innovation: For product developers, designing GLP-1 friendly foods will require new sensory approaches, emotional metrics and new nutritional architectures… Read more
- The Ozempic effect reaches the bread aisle: Bimbo redesigns bakery for GLP-1 users: The world’s biggest baker says GLP-1 weight-loss drugs are already reshaping how people eat, so it’s redesigning bread and snacks to keep up… Read more
- GLP‑1 drinks take off as brands race for $3.5bn functional growth: From protein shakes to collagen coolers, brands are reinventing beverages for the GLP‑1 era and the race for dominance in this fast‑growing $3.5bn category is just beginning… Read more
When customers go off the drugs
- After GLP-1: Weight regain, food fear and the industry’s next reckoning: With a growing number of people ditching GLP-1 weight-loss drugs, producers are being drawn into a far more complex conversation about nutrition, psychology and long-term eating behavior… Read more
- What happens after GLP-1s and why food will matter more than ever: Former GLP-1 users looking to keep the weight off are a potentially underserved consumer base looking for foods and beverages that will help the feel full longer, manage portions and meet their health goals… Read more
The marketing opportunities
- GLP-1 food boom: Market growth, big brands, and key challenges: GLP-1 fuels rapid food and beverage sector growth – but risks and costs mount… Read more
- GLP-1-friendly foods are booming – but the label is still taboo: From “high protein” to “supports muscle mass” claims, brands are coding GLP-1 benefits without naming the trend outright… Read more
- GLP-1 ranges: Should you launch one? We round up the challenges and opportunities of entering the ‘GLP-1 friendly’ meals arena… Read more
- Food cravings on GLP-1s? What formulators need to know: It’s a common misconception that GLP-1 drugs erase food cravings. Actually, they alter them… Read more
- Could the GLP-1 boom open the door to shrinkflation? Users of the drugs want smaller portions – this could help food companies save money… Read more
- Beyond GLP-1 drugs: How dietary ingredients can naturally support body’s own satiety hormone: As interest in GLP-1-based weight management grows, emerging data on a dietary ingredient suggest there could also be a more natural approach to control appetite and metabolic health…. Read more
